DesiCorp, Inc.
La Grange, KY · CIK 0001997477 · Medtech · Private
Dried blood products that are stored at ambient temperature and rapidly rehydrated for transfusion
desicorpinc.com →- Grants
- $532K
- 2 awards
- Sector median: 1
- Raised
- $1.8M
- 2 Form D · Apr 2026
- 6 months since last filing
- Contracts
- $75K
- 1 award · Defense
- #546 of 4531 in medtech
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Defense · Phase I · Development of Thermally Stable Whole Blood Product for Transfusion | $249,957 | |
| Federal contract | Department of Defense · Developing A Rehydration System For Lyophilized Blood Products | $74,698 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing a High-Flow Acoustofluidic Loading Platform for Research Cell Stabilization in the Anhydrous State | $281,873 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $839,993 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 543 | Objective Biotechnology, Inc. | $75K | $715K |
| 544 | Michael Francis | $75K | — |
| 545 | GENERAL OPTICS LLC | $75K | — |
| 546 | DesiCorp, Inc. | $75K | $1.8M |
| 547 | LUMO IMAGING LLC | $74K | — |
| 548 | RHEONIX, INC. | $73K | $45M |
| 549 | BIODESIX INC | $70K | $156M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Brett JanisDirector · Executive Officer
- Jonathan KopecheckDirector · Executive Officer
- Michael MenzeDirector · Executive Officer
- Robert SaundersDirector
Patents
- Adjustable Loading Deviceapplication
- Adjustable Loading Deviceapplication
- Adjustable Loading Deviceapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.